Frontiers in Cardiovascular Drug Discovery: Volume 6
Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
Introducing “Frontiers in Cardiovascular Drug Discovery: Volume 6”
Are you a medicinal chemist or pharmaceutical scientist involved in cardiovascular research? If so, then “Frontiers in Cardiovascular Drug Discovery” is a book series that you need to know about. The latest installment, “Volume 6,” provides a comprehensive overview of the latest advances in cardiovascular drug design and discovery. This volume covers a wide range of topics, from the biochemistry of cardiovascular therapy to the structure-activity relationships of molecules used in cardiovascular treatment.
The Importance of Cardiovascular Drug Discovery
Cardiovascular diseases continue to be a major health concern worldwide. Innovations in drug discovery play a crucial role in combating these diseases and improving patient outcomes. “Frontiers in Cardiovascular Drug Discovery” aims to keep researchers and scientists at the forefront of this rapidly evolving field by providing them with the latest insights and discoveries.
Volume 6 Highlights
Volume 6 of “Frontiers in Cardiovascular Drug Discovery” is packed with valuable content that will enhance your understanding of cardiovascular drug design and development. Here are just a few of the topics covered:
- Cardiovascular effects of ranolazine and the scope for translational research: a current review of literature
- Rho/Rho kinase signaling pathway and disease
- Hibernation or transformation? Challenges in cardiovascular drug development
- New approaches in P2Y12 receptor blocker drugs use
- Pathophysiological links between diabetes and cardiovascular diseases: at the biochemical and molecular levels
Why You Should Order “Frontiers in Cardiovascular Drug Discovery: Volume 6”
This book series offers a wealth of knowledge and insights that will benefit medicinal chemists and pharmaceutical scientists involved in cardiovascular research. By ordering “Frontiers in Cardiovascular Drug Discovery: Volume 6,” you will:
- Stay up-to-date with the latest advancements in cardiovascular drug design and discovery
- Gain valuable insights from experts in the field
- Enhance your understanding of the biochemistry and mechanisms of cardiovascular therapy
- Have access to reviews, in-silico drug design, combinatorial chemistry, high-throughput screening, and more
- Discover recent important patents and their impact on cardiovascular research
Order Now to Deepen Your Knowledge in Cardiovascular Drug Discovery
“Frontiers in Cardiovascular Drug Discovery: Volume 6” is a must-have resource for any researcher or scientist involved in cardiovascular drug discovery. This book series provides you with the latest advancements, reviews, and insights that will propel your research forward. Don’t miss out on this opportunity to deepen your knowledge and make a significant impact in the field of cardiovascular medicine. Order your copy today!
Product Details
- Publisher : Bentham Science Publishers (November 11, 2022)
- Language : English
- : 254 pages
- ISBN-10 : 9815036920
- ISBN-13 : 978-9815036923